Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

BUY
$0.83 - $2.26 $16,019 - $43,617
19,300 Added 18.17%
125,500 $133,000
Q3 2021

Nov 15, 2021

SELL
$4.84 - $6.91 $169,400 - $241,850
-35,000 Reduced 24.79%
106,200 $724,000
Q2 2021

Aug 16, 2021

BUY
$5.11 - $7.64 $200,312 - $299,488
39,200 Added 38.43%
141,200 $832,000
Q4 2020

Feb 16, 2021

BUY
$3.48 - $6.58 $87,000 - $164,500
25,000 Added 32.47%
102,000 $546,000
Q3 2020

Nov 16, 2020

BUY
$2.78 - $26.5 $5,560 - $53,000
2,000 Added 2.67%
77,000 $444,000
Q2 2020

Aug 14, 2020

BUY
$2.34 - $3.53 $175,500 - $264,750
75,000 New
75,000 $221,000

Others Institutions Holding EQ

About Equillium, Inc.


  • Ticker EQ
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 34,352,100
  • Market Cap $25.8M
  • Description
  • Equillium, Inc., a clinical-stage biotechnology company, develops and sells products to treat severe autoimmune and inflammatory, or immuno-inflammatory disorders with unmet medical need. The company's lead product candidate is itolizumab (EQ001), a clinical-stage monoclonal antibody that targets the novel immune checkpoint receptor CD6, which i...
More about EQ
Track This Portfolio

Track Bridgeway Capital Management, LLC Portfolio

Follow Bridgeway Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bridgeway Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bridgeway Capital Management, LLC with notifications on news.